author-photo

Orit Bar-Am

Technion – Israel Institute of Technology
Family Research Institute

61

Papers

3407

Citations

Citation Trend

Filter By

Papers (47) Sort By

Journal Conference Others

The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models

2017 Neuropharmacology
Show All
- Source
- Cite
- Save
Citations (23)
A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice.

2017 Neurotoxicity Research
Show All
- Source
- Cite
- Save
Citations (23)
Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets

2016 Journal of Neural Transmission
Show All
- Source
- Cite
- Save
Citations (27)
Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging

2015 Neurobiology of Aging
Show All
- Source
- Cite
- Save
Citations (53)
Beneficial behavioral, neurochemical and molecular effects of 1-(R)-aminoindan in aged mice

2015 Neuropharmacology
Show All
- Source
- Cite
- Save
Citations (9)
Molecular targets of the multifunctional iron‐chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus

2014 British Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (7)
The Novel Multi-Target Iron Chelator, M30 Modulates HIF-1α-Related Glycolytic Genes and Insulin Signaling Pathway in the Frontal Cortex of APP/PS1 Alzheimer’s Disease Mice

2014 Current Alzheimer Research
Show All
- Source
- Cite
- Save
Citations (25)
Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism

2013 Journal of Neural Transmission
Show All
- Source
- Cite
- Save
Citations (16)
Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase

2012 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (4)
I1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline

2012 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (9)